UNIGE document Scientific Article
previous document  unige:31993  next document
add to browser collection

Faut-il doser le BNP chez les patients avec BPCO

Marti, Christophec
Published in Revue médicale suisse. 2012, vol. 8, no. 358, p. 1961-5
Abstract The dosage of natriuretic peptides improves diagnostic performance in patients with acute dyspnea when combined with clinical elements. The high sensitivity of this test allows reasonably excluding heart failure when the value is normal. Nevertheless, an increased level of this biomarker is not specific of heart failure and can be observed in different pathologies such as renal failure, sepsis or elevated pulmonary arterial pressure. We therefore analyse the diagnostic performance of natriuretic peptide in COPD patients and discuss its use for the detection of heart failure in this population.
Keywords Biological Markers/bloodDyspnea/complicationsHeart Failure/diagnosisHumansNatriuretic Peptide, Brain/bloodPulmonary Disease, Chronic Obstructive/blood
PMID: 23198649
Full text
Article (Published version) (560 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://rms.medhyg.ch/numero-358-page-1961.htm
(ISO format)
GARIANI, Karim, PERRIER, Arnaud, MARTI, Christophec. Faut-il doser le BNP chez les patients avec BPCO. In: Revue médicale suisse, 2012, vol. 8, n° 358, p. 1961-5. https://archive-ouverte.unige.ch/unige:31993

413 hits

1 download


Deposited on : 2013-12-10

Export document
Format :
Citation style :